HLA-A structures
465 items
Page 12 of 19 | 25 items per page | ordered by release date, descending
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 194JFE |
HLA-A*02:01 presenting "ELAGIGALTV" to Alpha/Beta T cell receptor at 2.70Å resolution |
4JFF |
HLA-A*02:01 presenting "ELAGIGILTV" to Alpha/Beta T cell receptor at 2.43Å resolution |
4EUP |
HLA-A*02:01 presenting "ALGIGILTV" to Alpha/Beta T cell receptor at 2.88Å resolution |
4I4W |
HLA-A*02:01 binding "ILAKFLHRL" at 1.77Å resolution |
3V5K |
HLA-A*02:01 binding "KVAELVWFL" at 2.31Å resolution |
3V5H |
HLA-A*02:01 binding "KVAEIVHFL" at 1.63Å resolution |
3V5D |
HLA-A*02:01 binding "KVAELVHFL" at 2.00Å resolution |
4E5X |
HLA-A*02:01 binding "LLFGYPVYV" with Human adenovirus type 4 E3-19K at 1.95Å resolution |
4F7P |
HLA-A*24:02 binding "FYRYGFVANF" at 1.90Å resolution |
4F7T |
HLA-A*24:02 binding "RYGFVANF" at 1.70Å resolution |
4F7M |
HLA-A*24:02 binding "LYASPQLEGF" at 2.40Å resolution |
4GKS |
HLA-A*02:01 binding "FLTGIGIITV" at 2.35Å resolution |
4GKN |
HLA-A*02:01 binding "FATGIGIITV" at 2.75Å resolution |
3TO2 |
HLA-A*02:01 binding "LACFVLAAV" at 2.60Å resolution |
3RL2 |
HLA-A*03:01 binding "QVPLRPMTYK" at 2.39Å resolution |
3RL1 |
HLA-A*03:01 binding "AIFQSSMTK" at 2.00Å resolution |
3UTT |
HLA-A*02:01 presenting "ALWGPDPAAA" to Alpha/Beta T cell receptor at 2.60Å resolution |
3UTS |
HLA-A*02:01 presenting "ALWGPDPAAA" to Alpha/Beta T cell receptor at 2.71Å resolution |
3UTQ |
HLA-A*02:01 binding "ALWGPDPAAA" at 1.67Å resolution |
3REW |
HLA-A*02:01 binding "CLGGLLTMV" at 1.90Å resolution |
3QFJ |
HLA-A*02:01 presenting "LLFGFPVYV" to Alpha/Beta T cell receptor at 2.29Å resolution |
3QFD |
HLA-A*02:01 binding "AAGIGILTV" at 1.68Å resolution |
3NFN |
HLA-A*24:02 binding "RYPLTFGWCF" at 2.39Å resolution |
3QDG |
HLA-A*02:01 presenting "ELAGIGILTV" to Alpha/Beta T cell receptor at 2.69Å resolution |
3QEQ |
HLA-A*02:01 presenting "AAGIGILTV" to Alpha/Beta T cell receptor at 2.59Å resolution |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

This work is licensed under a Creative Commons Attribution 4.0 International License.